Nonprofit · EIN 75-2816066
MESOTHELIOMA APPLIED RESEARCH FOUNDATION INC
Tax-exempt · WASHINGTON, DC 20006
Financials
| Year ended | Form | Revenue | Expenses | Net income | Total assets | Liabilities | Net assets |
|---|---|---|---|---|---|---|---|
| December 31, 2025 | 990 | $2,531,496 | $1,542,060 | $989,436 | $11,531,357 | $457,681 | $11,073,676 |
| December 31, 2024 | 990 | $2,018,146 | $1,403,070 | $615,076 | $10,638,848 | $554,608 | $10,084,240 |
| December 31, 2023 | 990 | $1,546,869 | $1,532,223 | $14,646 | $9,971,454 | $546,462 | $9,424,992 |
Financial details: 990 for the year ended December 31, 2025
Revenue
- Contributions, gifts and grants
- $1,413,858
- Program service revenue
- $616,120
- Investment income
- $495,183
- Other revenue
- $6,335
Expenses
- Grants and similar amounts paid
- $411,047
- Compensation of officers, directors and key employees
- $282,777
- Other salaries and wages
- $257,862
- Salaries, compensation and benefits (total)
- $728,009
- Professional fundraising fees
- $0
- Legal fees
- $4,611
- Accounting fees
- $58,250
- Travel
- $17,110
- Depreciation
- $1,005
- Program services (functional)
- $1,169,993
- Management and general (functional)
- $144,320
- Fundraising (functional)
- $227,747
Balance sheet and other
- Total assets, start of year
- $10,638,848
- Total assets, end of year
- $11,531,357
- Total liabilities, end of year
- $457,681
- Net assets, end of year
- $11,073,676
- Land, buildings and equipment
- $1,693
- Publicly traded securities
- $8,831,022
- Net assets without donor restrictions
- $11,073,676
- Gross receipts
- $2,531,496
- Employees
- 6
- Volunteers
- 35
- Year formed
- 1999
- State of legal domicile
- DC
From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.
Officers, directors and key employees
As listed on the 990 for the year ended December 31, 2025, highest compensation first.
| Name | Title | Hours / week | Compensation |
|---|---|---|---|
| BRIAN LEPACEK | EXECUTIVE DIRECTOR | 40 | $153,217 |
| JULIE WHITE | PATIENT SRVS DIR | 40 | $138,975 |
| MARJORIE G ZAUDERER | CHAIR Trustee or director, Officer | 1 | $0 |
| R TAYLOR RIPLEY | VICE CHAIR Trustee or director, Officer | 1 | $0 |
| DARCIENA CHRISTEL | Treasurer Trustee or director, Officer | 1 | $0 |
| KEITH CENGEL | Secretary Trustee or director, Officer | 1 | $0 |
| JESSICA BLACKFORD-CLEETON | Board Member Trustee or director | 1 | $0 |
| CHERYL BURNER | Board Member Trustee or director | 1 | $0 |
| JASON FOSTER | Board Member Trustee or director | 1 | $0 |
| DANIEL STERMAN | Board Member Trustee or director | 1 | $0 |
| JAMES STEVENSON | Board Member Trustee or director | 1 | $0 |
| Bill Ziegler | Board Member Trustee or director | 1 | $0 |
990 for the year ended December 31, 2024: 15 people
| Name | Title | Hours / week | Compensation | Other / benefits |
|---|---|---|---|---|
| JULIE WHITE | HIGHEST COMPENSATED EMPLOYEE Highest-paid employee | 40 | $127,500 | $5,419 |
| BRIAN T LEPACEK | EXECUTIVE DIRECTOR Officer | 40 | $53,910 | $0 |
| MARJORIE G ZAUDERER MD MS FACP | CHAIR Trustee or director, Officer | 1 | $0 | $0 |
| DARCIENA ANDERSON CHRISTEL | TREASURER Trustee or director, Officer | 1 | $0 | $0 |
| R TAYLOR RIPLEY MD | VICE CHAIR Trustee or director, Officer | 1 | $0 | $0 |
| KEITH CENGEL MD PHD | SECRETARY Trustee or director | 1 | $0 | $0 |
| JASON M FOSTER MD | DIRECTOR Trustee or director | 1 | $0 | $0 |
| AARON S MANSFIELD MD | DIRECTOR (STEPPED DOWN IN 2024) Trustee or director | 1 | $0 | $0 |
| SANJAY POPAT PHD | DIRECTOR (STEPPED DOWN IN 2024) Trustee or director | 1 | $0 | $0 |
| BORIS SEPESI MD | DIRECTOR (MEMBERSHIP PAUSED IN 2024) Trustee or director | 1 | $0 | $0 |
| DANIEL STERMAN MD | DIRECTOR Trustee or director | 1 | $0 | $0 |
| JAMES STEVENSON MD | DIRECTOR Trustee or director | 1 | $0 | $0 |
| WILLIAM N ZIEGLER | DIRECTOR Trustee or director | 1 | $0 | $0 |
| CHERYL BRUNER ESQ | DIRECTOR Trustee or director | 1 | $0 | $0 |
| JESSICA BLACKFORD-CLEETON | DIRECTOR Trustee or director | 1 | $0 | $0 |
990 for the year ended December 31, 2023: 15 people
| Name | Title | Hours / week | Compensation | Other / benefits |
|---|---|---|---|---|
| MAJA BELAMARIC | COO Officer | 40 | $134,162 | $7,095 |
| JULIE POWERS | EXECUTIVE DIRECTOR Officer | 40 | $120,056 | $5,670 |
| MARJORIE G ZAUDERER MD MS FACP | CHAIR Trustee or director, Officer | 1 | $0 | $0 |
| DARCIENA ANDERSON CHRISTEL | TREASURER Trustee or director, Officer | 1 | $0 | $0 |
| R TAYLOR RIPLEY MD | SECRETARY Trustee or director, Officer | 1 | $0 | $0 |
| KEITH CENGEL MD PHD | DIRECTOR Trustee or director | 1 | $0 | $0 |
| JASON M FOSTER MD | DIRECTOR Trustee or director | 1 | $0 | $0 |
| AARON S MANSFIELD MD | DIRECTOR Trustee or director | 1 | $0 | $0 |
| SANJAY POPAT PHD | DIRECTOR Trustee or director | 1 | $0 | $0 |
| BORIS SEPESI MD | DIRECTOR Trustee or director | 1 | $0 | $0 |
| DANIEL STERMAN MD | DIRECTOR Trustee or director | 1 | $0 | $0 |
| JAMES STEVENSON MD | DIRECTOR Trustee or director | 1 | $0 | $0 |
| WILLIAM N ZIEGLER | DIRECTOR Trustee or director | 1 | $0 | $0 |
| CHERYL BRUNER ESQ | DIRECTOR Trustee or director | 1 | $0 | $0 |
| JESSICA BLACKFORD-CLEETON | DIRECTOR Trustee or director | 1 | $0 | $0 |
Address and contacts
- Address (IRS master file)
- 1717 K ST NW STE 900, WASHINGTON, DC 20006-5349
- In care of
- % MARY E HESDORFFER
- Principal officer (990 for 2025)
- DARCIENA CHRISTEL, 1717 K STREET NW 900, WASHINGTON, DC 20006
- Signed the 990
- DARCIENA CHRISTEL, Treasurer
- Phone
- (877) 363-6376
- Website
- WWW.CUREMESO.ORG
- Return prepared by
- HYDE & ASSOCIATES
Mission
TO OFFER HOPE AND SUPPORT TO PATIENTS AND FAMILIES DEALING WITH MESOTHELIOMA. THIS IS ACCOMPLISHED BY EDUCATING PATIENTS AND FAMILIES ABOUT THE DISEASE, HELPING THEM OBTAIN THE MOST UP-TO-DATE INFORMATION ON TREATMENT OPTIONS, CONNECTING THEM WITH MESOTHELIOMA TREATMENT SPECIALISTS, AND PROVIDING ASSISTANCE, EMOTIONAL SUPPORT, AND COMMUNITY WITH OTHERS. THE FOUNDATION PROVIDES FUNDING THE HIGHEST QUALITY AND MOST PROMISING MESOTHELIOMA RESEARCH PROJECTS WORLDWIDE THROUGH RIGOROUS PEER-REVIEW. THE FOUNDATION ALSO WORKS TO RAISE AWARENESS OF THE DISEASE, AND ADVOCATES THAT THE PUBLIC AND PRIVATE SECTORS PARTNER IN THE EFFORT TO CURE IT BY DIRECTING THE RESOURCES NEEDED TO STOP THIS GLOBAL TRAGEDY
Program accomplishments
- RESEARCH THE MESOTHELIOMA APPLIED RESEARCH FOUNDATION, INC. FUNDS THE MOST PROMISING MESOTHELIOMA RESEARCH PROJECTS GLOBALLY, AS DETERMINED BY A RIGOROUS PEER-REVIEW PROCESS VIA THE FOUNDATIONS SCIENCE ADVISORY BOARD AND APPROVED BY THE BOARD O DIRECTORS. THIS PROCESS IS BASED UPON THE DEPARTMENT OF DEFENCE CDMRP. BASED UPON THE NATIONAL CANCER INSTITUTE.Expenses $584,997 · grants $300,000
- EDUCATION SUPPORT AND SYMPOSIUM PATIENT SUPPORT SERVICES OFFERED BY THE MESOTHELIOMA APPLIED RESEARCH FOUNDATION, INC. INCLUDE PERSONALIZED CONSULTATIONS AND GUIDANCE THROUGH TREATMENT WITH MESOTHELIOMA EXPERTS. THIS INCLUDES PROVIDING PATIENTS WITH INFORMATION ABOUT TREATMENT OPTIONS, CONNECTING THEM WITH MESOTHELIOMA TREATMENT SPECIALISTS WHEN NEEDED, AND FACILITATING ACCESS TO THE FOUNDATIONS SUPPORT GROUPS.Expenses $350,996 · grants $18,353
- ADVOCACY THE MESOTHELIOMA APPLIED RESEARCH FOUNDATION, INC. ADVOCATES ON BEHALF OF ITS PATIENTS AND FAMILIES FOR INCREASED FUNDING OF MESOTHELIOMA RESEARCH THROUGH FEDERAL INVESTMENT.Expenses $234,000 · grants $92,695
What it must file and when
IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in December, so each return is due on the 15th day of the 5th month after that.
| Tax year | Year ended | Due | IRS public records |
|---|---|---|---|
| 2025 | December 31, 2025 | May 15, 2026 | 990 on file |
| 2024 | December 31, 2024 | May 15, 2025 | 990 on file |
| 2023 | December 31, 2023 | May 15, 2024 | 990 on file |
IRS record
- EIN
- 75-2816066
- Tax-exempt status
- 501(c)(3): Charitable, religious, educational or scientific organization
- Foundation status
- Publicly supported organization (170(b)(1)(A)(vi))
- Donations deductible (Pub 78)
- Public charity, 50% deduction limit
- Exempt since
- 2000
- Accounting year ends
- December
- Files
- Form 990 or 990-EZ
- Category (NTEE)
- Voluntary health associations and medical disciplines (G128)
- Assets (IRS master file)
- $11,531,357
- Income (IRS master file)
- $2,531,496
Filing history
| Form | Year ended | Revenue | Expenses | Assets | Return |
|---|---|---|---|---|---|
| 990 | December 2025 | $2,531,496 | $1,542,060 | $11,531,357 | XML |
| 990 | December 2024 | $2,018,146 | $1,403,070 | $10,638,848 | XML |
| 990 | December 2023 | $1,546,869 | $1,532,223 | $9,971,454 | XML |
| 990 | December 2022 | $1,693,216 | $1,190,526 | $9,449,879 | IRS |
| 990 | December 2021 | – | – | – | IRS |
| 990 | December 2020 | – | – | – | IRS |
| 990 | December 2018 | – | – | – | IRS |
990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 75-2816066).
Questions about MESOTHELIOMA APPLIED RESEARCH FOUNDATION INC
- What is the EIN of MESOTHELIOMA APPLIED RESEARCH FOUNDATION INC?
- The employer identification number (EIN) of MESOTHELIOMA APPLIED RESEARCH FOUNDATION INC is 75-2816066.
- Is MESOTHELIOMA APPLIED RESEARCH FOUNDATION INC tax-exempt?
- Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 2000.
- Are donations to MESOTHELIOMA APPLIED RESEARCH FOUNDATION INC tax-deductible?
- Yes. It is listed in IRS Publication 78 (Public charity, 50% deduction limit).
- Which annual return does MESOTHELIOMA APPLIED RESEARCH FOUNDATION INC file?
- Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
- When is the next return of MESOTHELIOMA APPLIED RESEARCH FOUNDATION INC due?
- The return for tax year 2026 (the year ending December 31, 2026) is due May 17, 2027. Form 8868 extends it by six months; the 990-N cannot be extended.
- When did MESOTHELIOMA APPLIED RESEARCH FOUNDATION INC last file with the IRS?
- The latest return in the IRS public files is the 990 for the year ended December 2025.
- Who is the principal officer of MESOTHELIOMA APPLIED RESEARCH FOUNDATION INC?
- The 990 for the year ended December 31, 2025 names DARCIENA CHRISTEL.
- Who are the officers and directors of MESOTHELIOMA APPLIED RESEARCH FOUNDATION INC?
- The 990 for the year ended December 31, 2025 lists 12 people; 2 received compensation from the organization, the highest $153,217 (BRIAN LEPACEK, EXECUTIVE DIRECTOR).
- How much revenue does MESOTHELIOMA APPLIED RESEARCH FOUNDATION INC have?
- On its 990 for the year ended December 31, 2025 it reported revenue of $2,531,496, expenses of $1,542,060 and total assets of $11,531,357 at year end.
Other nonprofits in WASHINGTON
- BLOOD CANCER UNITED INC EIN 13-5644916 · last filed 990 for 2025
- AMERICAN COLLEGE OF CARDIOLOGY FOUNDATION EIN 13-5641985 · last filed 990 for 2024
- AMERICAN SOCIETY OF HEMATOLOGY INC EIN 23-7080568 · last filed 990 for 2025
- WHITMAN-WALKER CLINIC INC EIN 52-1122122 · last filed 990 for 2024
- OPTICAL SOCIETY OF AMERICA INC EIN 53-0259696 · last filed 990 for 2024
- AUTISM SPEAKS INC EIN 20-2329938 · last filed 990 for 2025
- ENDOCRINE SOCIETY EIN 73-0531256 · last filed 990 for 2024
- FOOD & FRIENDS INC EIN 52-1648941 · last filed 990 for 2025
All nonprofits in WASHINGTON · District of Columbia · Voluntary health associations and medical disciplines